Schedule Your Exam
On-Demand Web Module
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.
Greg Patterson, MD, FACS, CWS
General and Vascular Surgery, Bariatric and Metabolic Surgery
Archbold Center for Wound Management and Hyperbaric Medicine
Pamela Scarborough, PT, DPT, MS, CDE, CWS, CEEAA
Director of Public Policy and Education
American Medical Technologies
Dot Weir, RN, CWOCN, CWS
Advanced Wound Healing Center
Cheektowaga, New York
After completing this activity, participants should be able to:
- Outline the etiology of chronic wounds and extrinsic factors that contribute to and affect wound healing outcomes.
- Describe the phases of wound healing and the associated microenvironment, cellular components, and their functions in wound healing.
- Identify the anatomy of the skin and other important structures.
- Assess research and evidence related to wound management.
- Describe specific diagnostic tests, examination tests, lab tests, and measures related to wound assessment and management.
- Identify the components of wound assessment and documentation.
- Identify methods for recognizing soft tissue and bone infections, bioburden management and treatment of local and systemic infections.
- Discuss nutritional factors and the underlying deficiencies that impact wound healing.
- Relate the psychosocial and cognitive aspects to patient outcomes in wound repair.
- Describe specific treatment interventions for chronic wounds including debridement, topical therapies, and biophysical agents.
Physicians, Pharmacists, Podiatrists, Wound Care Surgeons, Nurse Practitioners, Physician Assistants, Masters Prepared Nurses, Registered Nurses, Associate Degree Nurses, Dietitians, and Sales and Marketing Specialists within wound care.
This on-demand webcast is available with synchronized slides and audio.
To be eligible for documentation of credit, participants must complete the educational activity, complete the 30-question post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com/program/2014-590-11, participants may immediately print their documentation of credit.
After purchasing access to WCPC On-Demand, participants have 90 days of unlimited access to view the entire program as often as they wish.
Release date: March 19, 2015
Expiration date: March 19, 2018
Estimated time to complete: 15.25 hours
ACPE Credit Policy
Your official record of ACPE credit will be generated through the CPE Monitor System. The certificate printed from this website after completing the evaluation for this activity is for personal tracking purposes only.
Eligibility for pharmacy credit is contingent upon the successful completion of a post-test and/or evaluation for each activity or session attended. Please note that you must complete the activity evaluation within 60 days of a live activity or within 60 days of beginning the evaluation for an enduring activity. Under ACPE Policy, NACCME will not be able to report your activity completion to CPE Monitor after this 60-day period.
All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested (please download here) for video programs. A PDF reader is required for print publications. Please direct technical questions to firstname.lastname@example.org.
In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
NACCME designates this enduring material for a maximum of 15.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing nursing education activity awards 15.25 contact hours.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 15.25 contact hours.
This activity is approved for 15.25 contact hours (15.25 CEU) of continuing pharmacy education (UAN 0276-0000-15-078-H01-P).
Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact the Senior Manager of Accreditation and Compliance, NACCME, in writing at 104 Windsor Center Drive, Suite 200, East Windsor, NJ 08520, or by email at email@example.com. The Senior Manager of Accreditation and Compliance will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation and Compliance, NACCME, may be made for a second level of review.
This educational activity is a knowledge-based activity.
Illinois Physical Therapy Association: This symposium has been approved for 15.25 contact hours. (Sponsor License # 216000302)
North American Center for Continuing Medical Education, LLC (NACCME), is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 15.25 continuing professional education units for completion of this activity/material.
CDR Accredited Provider #HM001, Level 3 Synthesis
Continuing Podiatric Education
North American Center for Continuing Medical Education, LLC (NACCME) is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. NACCME has approved this activity for a maximum of 15.25 continuing education contact hours.
Independent Clinical Reviewer: Daniel Federman, MD, FACP, Yale University School of Medicine, Newton, Connecticut
Nurse Planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, California
The planning committee comprises Carolyn Cuttino, BSN, RN, CWCN; Daniel Federman, MD, FACP; Greg Patterson, MD, FACS, CWS; Lee C. Ruotsi, MD, CWS, UHM; Pamela Scarborough, PT, DPT, MS, CDE, CWS, CEEAA; Hollie Mangrum, PT, DPT, CWS; Susie Seaman, NP; Dot Weir, RN, CWON, CWS; and Stephanie Kunyz, Tiffney Oliver, Randy Robbin, and Susan Yarbrough of NACCME.
Financial Disclosures and Conflicts of Interest
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Ms. Cuttino: Promotional Speakers’ Bureau–Smith and Nephew Biotherapeutics.
Dr. Ruotsi: Promotional Speakers’ Bureau–Smith and Nephew Biotherapeutics, BSN; Promotional Speakers’ Bureau–Smith and Nephew Biotherapeutics
Ms. Scarborough: Employee–American Medical Technologies
Ms. Mangrum: Employee–Healogics, Inc.
Ms. Weir: Consultant–Medline; Promotional Speakers’ Bureau–Lohmann & Rauscher, Hollister, Mölnlycke Healthcare, LLC, Organogenesis, Smith & Nephew, Acelity; Advisory Board–Mölnlycke
Dr. Federman, Dr. Patterson, Ms. Seaman, Ms. Kunyz, Ms. Oliver, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
Off-label/unapproved uses of drugs and/or devices will be disclosed prior to the presentation.
No commercial interest provided financial support for this continuing education activity.
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2017 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.